MARC보기
LDR05600cmm u2200685Mu 4500
001000000313948
003OCoLC
00520230525163540
006m d
007cr |n|||||||||
008160123s2017 xx ob 001 0 eng d
019 ▼a 934197853 ▼a 950429094 ▼a 973368074 ▼a 973530550 ▼a 982405356 ▼a 985632212 ▼a 985758214 ▼a 1001273304
020 ▼a 9781284057515 ▼q (electronic bk.)
020 ▼a 1284057518 ▼q (electronic bk.)
020 ▼z 9781284057485
020 ▼z 1284057488
035 ▼a 993259 ▼b (N$T)
035 ▼a (OCoLC)935254693 ▼z (OCoLC)934197853 ▼z (OCoLC)950429094 ▼z (OCoLC)973368074 ▼z (OCoLC)973530550 ▼z (OCoLC)982405356 ▼z (OCoLC)985632212 ▼z (OCoLC)985758214 ▼z (OCoLC)1001273304
040 ▼a EBLCP ▼b eng ▼e pn ▼c EBLCP ▼d YDXCP ▼d VRC ▼d OCLCQ ▼d AJB ▼d OCLCO ▼d YDX ▼d OCLCO ▼d CUS ▼d N$T ▼d JDR ▼d LGG ▼d OCLCA ▼d PFM ▼d OCLCQ ▼d 248032
049 ▼a MAIN
050 4 ▼a RG131 ▼b .P43 2017
060 4 ▼a QV 37 ▼b P536 2017
072 7 ▼a MED ▼x 071000 ▼2 bisacsh
08204 ▼a 615/.1082 ▼2 23
1001 ▼a Brucker, Mary C.
24510 ▼a Pharmacology for women's health. ▼h [electronic resource]
250 ▼a 2nd ed.
260 ▼b Jones & Bartlett Learning, ▼c 2017.
300 ▼a 1 online resource (1230 pages)
336 ▼a text ▼b txt ▼2 rdacontent
337 ▼a computer ▼b c ▼2 rdamedia
338 ▼a online resource ▼b cr ▼2 rdacarrier
500 ▼a Future Pharmacotherapies for Substance Use Disorders.
504 ▼a Includes bibliographical references and index.
5050 ▼a Title; Copyright; Contents; Introduction; Acknowledgments; Contributors; Section I Introduction to Pharmacology; Chapter 1 Modern Pharmacology; Chapter Glossary; Society and Health; Categories of Drugs; Drug Development and Approval; Regulation of Approved Pharmaceuticals; The Role of the Pharmacist; The Cost of Drugs in Modern Society; Special Populations; Rational Prescribing; How to Write a Prescription; Conclusion; Resources; References; Chapter 2 Principles of Pharmacology; Chapter Glossary; Introduction; The Nature of Drugs; Pharmacokinetics; Pharmacodynamics; Pharmacotherapy.
5058 ▼a ConclusionResources; References; Chapter 3 Pharmacogenetics; Chapter Glossary; Introduction; Background; Genomic Differences in Pharmacokinetics: Drug Metabolism and Drug Disposition; Genomic Differences in Pharmacodynamics: Drug Response; The Future of Pharmacogenomics; Conclusion; Resources; References; Chapter 4 Drug Toxicity; Chapter Glossary; Introduction; Adverse Drug Reactions; Classification of Adverse Drug Reactions; Clinical Manifestations of Drug Reactions and Toxicity; Preventing Adverse Drug Reactions; Poisoning; Toxicity from Heavy Metals; Endocrine Disruptors; Conclusion.
5058 ▼a ResourcesReferences; Section II Lifestyle and Preventive Healthcare Practices; Chapter 5 Vitamins and Minerals; Chapter Glossary; Introduction; Dietary Reference Intake Guidelines; Regulation of Dietary Supplements in the United States; Vitamins; Minerals; Multivitamin/Multimineral Supplements; Supplementation for Women After Bariatric Surgery; Special Populations: Pregnancy, Lactation, and the Elderly; Conclusion; Resources; References; Chapter 6 Immunizations; Chapter Glossary; Historical Review; Public Health Impact of Vaccination Programs; Basics of Immunity; Vaccine Products.
5058 ▼a Factors Affecting Responses to VaccinesVaccine Schedules; Common Vaccines for Women; Vaccine Safety; Special Populations; Conclusion; Resources; References; Chapter 7 Drugs to Promote Optimum Weight; Chapter Glossary; Introduction; Overweight and Obesity; Physiology of Weight Gain and Loss; Diseases Associated with Weight Alterations; Obesigenic Medications; Weight Loss Guidelines; Pharmacokinetics and Pharmacodynamics of Weight Optimization Drugs; Nonpharmacologic Weight Loss Methods; Special Populations; Conclusion; Resources; References; Chapter 8 Smoking Cessation; Chapter Glossary.
5058 ▼a IntroductionTobacco Use Among Women; Physiology of Tobacco Addiction; Initiating Smoking Cessation; Nicotine Replacement Therapy; Non-Nicotine Pharmacologic Therapies; Combination Therapy; Electronic Cigarettes and Mobile Vaporizer Units: Smoking Cessation Products or Just a Sales Smokescreen?; Future Therapy; Special Populations; Conclusion; Resources; References; Chapter 9 Drugs of Abuse; Chapter Glossary; Introduction; Neurobiology of Addiction; Treatment of Individuals with Substance Use Disorders; Women and Substance Use Disorders; Pharmacotherapy of Drugs of Abuse.
5880 ▼a Print version record.
590 ▼a Master record variable field(s) change: 050
650 0 ▼a Gynecologic drugs.
650 0 ▼a Women ▼x Diseases ▼x Chemotherapy.
650 0 ▼a Women ▼x Health and hygiene.
65012 ▼a Pharmacological Phenomena.
65022 ▼a Genital Diseases, Female ▼x drug therapy.
65022 ▼a Pregnancy Complications ▼x drug therapy.
65022 ▼a Women's Health.
650 7 ▼a MEDICAL ▼x Pharmacology. ▼2 bisacsh
650 7 ▼a Gynecologic drugs. ▼2 fast ▼0 (OCoLC)fst00949667
650 7 ▼a Women ▼x Diseases ▼x Chemotherapy. ▼2 fast ▼0 (OCoLC)fst01176641
650 7 ▼a Women ▼x Health and hygiene. ▼2 fast ▼0 (OCoLC)fst01176758
655 4 ▼a Electronic books.
7001 ▼a King, Tekoa L.
77608 ▼i Print version: ▼a Brucker, Mary C. ▼t Pharmacology for Women's Health. ▼d : Jones & Bartlett Learning, 짤2017 ▼z 9781284057485
85640 ▼3 EBSCOhost ▼u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=993259
938 ▼a EBL - Ebook Library ▼b EBLB ▼n EBL4305899
938 ▼a EBSCOhost ▼b EBSC ▼n 993259
938 ▼a YBP Library Services ▼b YANK ▼n 12779833
990 ▼a 관리자
994 ▼a 92 ▼b N$T